|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn162128811 |
003 |
OCoLC |
005 |
20231117014741.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
070802s1997 caua ob 001 0 eng d |
040 |
|
|
|a OPELS
|b eng
|e pn
|c OPELS
|d OPELS
|d BAKER
|d OCLCQ
|d N$T
|d YDXCP
|d CDX
|d OCLCE
|d IDEBK
|d E7B
|d OCLCQ
|d GBVCP
|d OCLCO
|d NLGGC
|d OCLCF
|d CHVBK
|d DEBSZ
|d OCLCQ
|d UAB
|d OCLCQ
|d CASUM
|d OCLCO
|d OCLCA
|d STF
|d D6H
|d OCLCO
|d OCLCQ
|d OCLCA
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCLCQ
|d OCLCO
|d INARC
|
016 |
7 |
|
|a 573155739
|2 DE-101
|
019 |
|
|
|a 173482583
|a 233792291
|a 606008459
|a 648314582
|a 658507105
|a 815542407
|a 823111639
|a 823830877
|a 823900617
|a 824091916
|a 824141916
|a 987697510
|a 1011236716
|a 1035699008
|a 1086441217
|a 1160031692
|
020 |
|
|
|a 9780123049902
|
020 |
|
|
|a 0123049903
|
020 |
|
|
|a 9780080537450
|q (electronic bk.)
|
020 |
|
|
|a 0080537456
|q (electronic bk.)
|
020 |
|
|
|a 1281118931
|
020 |
|
|
|a 9781281118936
|
035 |
|
|
|a (OCoLC)162128811
|z (OCoLC)173482583
|z (OCoLC)233792291
|z (OCoLC)606008459
|z (OCoLC)648314582
|z (OCoLC)658507105
|z (OCoLC)815542407
|z (OCoLC)823111639
|z (OCoLC)823830877
|z (OCoLC)823900617
|z (OCoLC)824091916
|z (OCoLC)824141916
|z (OCoLC)987697510
|z (OCoLC)1011236716
|z (OCoLC)1035699008
|z (OCoLC)1086441217
|z (OCoLC)1160031692
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QP552.N38
|b N48 1997
|
060 |
|
4 |
|a WL 104
|
072 |
|
7 |
|a MED
|x 008000
|2 bisacsh
|
072 |
|
7 |
|a MJG
|2 bicssc
|
082 |
0 |
4 |
|a 612/.015756
|2 22
|
245 |
0 |
0 |
|a Neuropeptide Y and drug development /
|c edited by Lars Grundemar and Stephen R. Bloom.
|
260 |
|
|
|a San Diego :
|b Academic Press,
|c �1997.
|
300 |
|
|
|a 1 online resource (xii, 209 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a Neuropeptide Y (NPY) is a ubiquitous and important messenger in the nervous system, with a wide range of physiological roles. It is involved in the body energy balance and is one of the most potent stimuli of food intake known. NPY also acts to regulate central and peripheral autonomic functions. This book, written by academic and industrial experts in the field, links the most recent basic experimental knowledge about NPY and its receptors with areas of clinical importance. This book will be of interest to those working in all areas of research affected by NPY, such as food intake and energy homeostasis, cardiovascular regulation and G-protein-coupled receptors, as well as those interested in the development of drugs as NPY targets. Key Features * The hypothalamic role of NPY and its relationship with eating disorders and diabetes * The sympathetic nervous system role of NPY and its involvement in cardiovascular disorders * Characterization of NPY receptor types and their brain distribution, molecular biology and pharmacology * Development of peptide and non-peptide receptor antagonists.
|
505 |
0 |
|
|a Multiple Receptors and Multiple Actions. Central Effects of Neuropeptide Y and Its Role in Obesity and Diabetes. Neuropeptide Y in Sympathetic Nerves-Evidence for Y1 Receptor-Mediated Vascular Control. Neuropeptide Y Receptor Types in Mammalian Brain. Species Differences and Status in the Human Central Nervous System. Extraordinary Structural Diversity of Neuropeptide Y Family Receptors. The Importance of Various Parts of the Neuropeptide Y Molecule for Receptor Recognition. Peptide Antagonists of Neuropeptide Y: Design, Structure, And Pharmacological Characterization. SR 120819A or the First Generation of Orally-Active Neuropeptide Y1 Receptor Antagonists. BIBP3226, A Potent and Selective Y1 Receptor Antagonist. First Structure-Activity Studies and Localization of the Human Y1 Receptor Binding Site. Discovery of Neuropeptide Y Receptor Antagonists. Subject Index.
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
650 |
|
0 |
|a Neuropeptide Y.
|
650 |
|
2 |
|a Neuropeptide Y
|x metabolism
|0 (DNLM)D009478Q000378
|
650 |
|
2 |
|a Neuropeptide Y
|0 (DNLM)D009478
|
650 |
|
6 |
|a Neuropeptide Y.
|0 (CaQQLa)201-0208270
|
650 |
|
7 |
|a MEDICAL
|x Biochemistry.
|2 bisacsh
|
650 |
|
7 |
|a Neuropeptide Y
|2 fast
|0 (OCoLC)fst01036449
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Grundemar, Lars.
|
700 |
1 |
|
|a Bloom, Stephen Robert.
|
776 |
0 |
8 |
|i Print version:
|t Neuropeptide Y and drug development.
|d San Diego : Academic Press, �1997
|z 0123049903
|z 9780123049902
|w (OCoLC)36203424
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123049902
|z Texto completo
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123049902
|z Texto completo
|